Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × poly ICLC × 30 days × Clear all

Sponsor

Conditions

Smoldering Multiple Myeloma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma 1 Anemia, Refractory 1

Interventions

Bevacizumab 14 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 7 lenvatinib 5 Radiosurgery 5 pembrolizumab 4 X-Rays 4 Sorafenib 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Cyclophosphamide 4 Immunoglobulin G 3 E-7386 3 Blood Specimen Collection 3 tremelimumab 2 sintilimab 2 regorafenib 2 fludarabine 2 cabozantinib 2 Disulfides 2 Biopsy 2 tislelizumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡